Vijaya Diagnostic Centre Reports Robust Q2 FY27 Results with 37.4% YoY PAT Growth
Vijaya Diagnostic Centre Ltd 路 Investor Presentation 路 04 Nov 2026, 2:03 am
Vijaya Diagnostic Centre Reports Robust Q2 FY27 Results with 37.4% YoY PAT Growth Vijaya Diagnostic Centre delivered strong Q2 FY27 performance, with revenue from operations growing 26.7% YoY to INR 2,554 Mn, driven by a 16.5% YoY rise in test volumes to 4.98 Mn and 14.5% footfall growth. EBITDA increased 37.8% YoY to INR 1,128 Mn with margins expanding 355 bps to 44.1%. PAT surged 37.4% YoY to INR 595 Mn. The B2C segment maintained a 92% revenue share. Strategically, the company expanded into the North-East by signing a BTA to acquire Arya Wellness Centre for INR 462 Mn.
Original exchange filing (PDF)
More announcements from Vijaya Diagnostic Centre Ltd
- Transcript of the Earnings Call for Q2 FY27 Financial Results held on November 04, 2026 路 07 Nov 2026
- Audio recording of the Earning Conference Call for Q2 - FY 2027 路 04 Nov 2026
- Press-release on unaudited Financial Results for the Quarter and half year ended September 30, 2026 路 04 Nov 2026
- Appointment of Mr. Rahul Jain (ICSI M. No. A62949), as Company Secretary and Compliance Officer of the Company 路 04 Nov 2026
- Submission of the Unaudited Financial Results for the Quarter and Half year ended September 30, 2026 路 04 Nov 2026
- The Board of Directors in their meeting held on November 03, 2026 have approved the financial results for the quarter and Half year ended September 30, 2026 路 04 Nov 2026
- Vijaya Diagnostic Centre Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 04 Nov 2026
- Vijaya Diagnostic Centre Limited has informed the Exchange about Board Meeting to be held on 03-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . 路 03 Nov 2026
